Chongqing Precision Biotech Co., Ltd.

Cn
En

INNOVATION FOR HEALTH

BUILD A GLOBAL AND INNOVATIVE BIOPHARMACEUTICAL ENTERPRISE

Production technology platform

Basic research and development platform

Planning to build Chongqing Regional Cell Preparation Center

ABOUT US

18000_㎡

IND and NDA Platforms For Cell-based Drug

159₊

R&D Elite

10₊

Pipeline

4

Class I New Drugs

9

Indication

43

Patents

CORPORATE
CULTURE

MANAGEMENT
TEAM

PIPELINE

R&D PLATFORM

CORE TECHNOLOGY

MANUFACTURING

NEWS & INFORMATION

Exclusive Interview with Professor Qian Cheng, Chairman of Precision Biotech: Successfully Broken through the CAR-T Track, and the First Domestic CAR-T cell Drug for Pediatric Leukemia Is about to Be Approved

Exclusive Interview with Professor Qian Cheng, Chairman of Precision Biotech: Successfully Broken through the CAR-T Track, and the First Domestic CAR-T cell Drug for Pediatric Leukemia Is about to Be Approved

Another Weighty Honor! Precision Biotech Selected for "Kechuang China" New Sharp Enterprise List

On July 2nd, China Association for Science and Technology released the list of "Kechuang China" in 2023 at the 26th annual meeting.

Chongqing Precision Biotech Announced the NMPA Acceptance of the New Drug Application for Priscabtagene Autoleucel Injection, China’s first CAR-T Product For The Treatment of Childhood Leukemia

On July 20, 2024,Chongqing Precision Biotech Announced the NMPA Acceptance of the New Drug Application for Priscabtagene Autoleucel Injection.

Professor Qian Cheng, Chief Scientist of Chongqing Precision Biotech, Awarded "Top Ten Scientists for Drug Innovation"

On June 20th, the high-profile 4th Annual Selection and Awarding Conference of Drug Innovation Award was held in Shanghai.

FOLLOW US ON WECHAT

© Copyright 2016-2024 重庆精准生物技术有限公司 All Rights Reserved

渝ICP备16003030号-1

渝公网安备 50010702505019号

Design By:zhiing